Found 5 results

Name Type of Offering Accepted Date
Life Biosciences LLC See All Filings
D 2018-08-31 16:47:41
Amount To Be Raised $25,000,000
Associated Brokers / Dealers N/A
CIK Number 0001751806
Filed Document 0001751806-18-000003
Exclusions or Exemptions 506c
Accepted Date 2018-08-31 16:47:41
Type of Offering D
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Life Biosciences LLC See All Filings
D/A 2021-06-11 14:23:59
Amount To Be Raised $99,999,997
Associated Brokers / Dealers N/A
CIK Number 0001751806
Filed Document 0001751806-21-000001
Exclusions or Exemptions 506b
Accepted Date 2021-06-11 14:23:59
Type of Offering D/A
Industry Other
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Life Biosciences LLC See All Filings
D 2020-09-23 14:20:40
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001751806
Filed Document 0001751806-20-000003
Exclusions or Exemptions 506b
Accepted Date 2020-09-23 14:20:40
Type of Offering D
Industry Other
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Life Biosciences LLC See All Filings
D 2020-06-12 13:51:28
Amount To Be Raised $99,999,997
Associated Brokers / Dealers N/A
CIK Number 0001751806
Filed Document 0001751806-20-000002
Exclusions or Exemptions 506b
Accepted Date 2020-06-12 13:51:28
Type of Offering D
Industry Other
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Life Biosciences LLC See All Filings
D/A 2018-12-31 20:48:39
Amount To Be Raised $50,924,755
Associated Brokers / Dealers N/A
CIK Number 0001751806
Filed Document 0001751806-18-000004
Exclusions or Exemptions 506c
Accepted Date 2018-12-31 20:48:39
Type of Offering D/A
Industry Other
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity